RBC Capital analyst Kaan Peker maintained a Buy rating on Mineral Resources Limited (MALRF – Research Report) on January 30 and set a price ...
RBC Capital Markets increased its price target on Celestica (NYSE:CLS) shares from $115.00 to $140.00 while maintaining an Outperform rating. Currently trading at $131.66, near its 52-week high, ...
In a report released yesterday, Daniel Perlin from RBC Capital maintained a Buy rating on Mastercard (MA – Research Report), with a price ...
LONDON - Rio Tinto Group and Glencore have been discussing combining their businesses, which if successful would rank as the largest-ever mining deal and create a US$158 billion ($216 billion ...
RBC Capital Markets has promoted Adam Ragol-Levy to head of European and Asian product, multi-asset agency solutions. The appointment follows three years serving as global multi-asset product manager ...
A BOJ hike would be contingent on markets staying calm when Donald Trump returns to the White House next Monday. His inauguration speech will be a focus for politicians and policymakers across the ...
In recent years, RBC Capital Markets’ CMT effort in Europe has gravitated towards clients and deals linked with infrastructure, and the bank is building up its European communications ...
RBC Capital Markets analyst Pammi Bir published a look ahead to 2025 for REITs and emphasized four top picks, Scotiabank analyst Ovais Habib expects significant profit margin growth for precious ...
On Tuesday, RBC Capital Markets adjusted its price target for Sherwin-Williams (NYSE:SHW) stock, listed on the New York Stock Exchange under the ticker NYSE:SHW, reducing it to $438 from the ...
On Tuesday, RBC (TSX:RY) Capital Markets adjusted its price target for Canadian Natural Resources Limited (TSX:CNQ:CN) (NYSE: CNQ), bringing it down to Cdn$62.00 from the previous Cdn$63.00. The ...
Street Talk understands the Wall Street firm’s head of equity capital markets and head of syndicate left the firm just before Christmas and annual bonus season. Lamshed joined Goldman Sachs in ...
Capital markets day postponed due to CEO medical procedure Weaker production, refining margins and trading to hit profit Shares down nearly 3% after underperforming peers in past year Jan 14 ...